Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
PubMed
28466888
DOI
10.1039/c7cc01946g
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminescent cyclometalated iridium(iii) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.
Citace poskytuje Crossref.org
